The reassessment of ovarian cancer in complete clinical remission: what are our goals?
Clarke-Pearson
D L
DL
D000911:Antibodies, Monoclonal; D015295:Antigens, Tumor-Associated, Carbohydrate / Q000097:blood; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006040:Goals; D006801:Humans; D008495:Medical Oncology / Q000379:methods; D010051:Ovarian Neoplasms / Q000097:blood / Q000000981:diagnostic imaging / Q000188:drug therapy*; D012074:Remission Induction; D014057:Tomography, X-Ray Computed
D000911:Antibodies, Monoclonal; D015295:Antigens, Tumor-Associated, Carbohydrate; D000970:Antineoplastic Agents